EATON DAN L has a total of 13 patent applications. Its first patent ever was published in 1994. It filed its patents most often in United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are PROMETHEUS BIOSCIENCES INC, AVA LIFESCIENCE GMBH and CONSENSUS PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Eaton Dan L | 13 |
#2 | De Sauvage Frederic J | 7 |
#3 | Pisabarro Maria T | 4 |
#4 | Wood William I | 4 |
#5 | Schmidt Kerstin N | 4 |
#6 | Watanabe Colin K | 4 |
#7 | Vandlen Richard | 4 |
#8 | Grimaldi J C | 3 |
#9 | Chiang Nancy | 2 |
#10 | Williams P M | 2 |
Publication | Filing date | Title |
---|---|---|
US2006160186A1 | Nucleic acid underexpressed in stomach tumor and lung tumor | |
US2008286821A1 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
US2007003545A9 | Interleukin-8 homologous polypeptides and therapeutic uses thereof | |
US8278099B1 | Monoclonal antibody to human thrombopoietin | |
US8241900B1 | mpl ligand | |
US8147844B1 | Mpl ligand (thrombopoietin), nucleic acids encoding such, and methods of treatment using mpl ligand | |
US8192955B1 | Nucleic acids encoding MPL ligand (thrombopoietin), variants, and fragments thereof |